121 related articles for article (PubMed ID: 35172376)
1. Changes in five-year survival for people with acute leukaemia in South Australia, 1980-2016.
Beckmann K; Kearney BJ; Yeung D; Hiwase D; Li M; Roder DM
Med J Aust; 2022 Apr; 216(6):296-302. PubMed ID: 35172376
[TBL] [Abstract][Full Text] [Related]
2. Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race?
Jessop S; Ruhayel S; Sutton R; Youlden DR; Pearson G; Lu C; Milne S; Henderson MJ; Aitken JF; Kotecha RS; Revesz T
Pediatr Blood Cancer; 2021 Apr; 68(4):e28945. PubMed ID: 33565233
[TBL] [Abstract][Full Text] [Related]
3. Myeloid leukaemia treatment and survival--the South Australian experience, 1977 to 2002.
Luke C; Nguyen AM; To B; Seshadri R; Hughes T; Bardy P; Colbeck M; Buranyi-Trevarton D; McMellon M; Roder D
Asian Pac J Cancer Prev; 2006; 7(2):227-33. PubMed ID: 16839214
[TBL] [Abstract][Full Text] [Related]
4. Differences in impact of Aboriginal and Torres Strait Islander status on cancer stage and survival by level of socio-economic disadvantage and remoteness of residence-A population-based cohort study in Australia.
Tervonen HE; Aranda S; Roder D; Walton R; Baker D; You H; Currow D
Cancer Epidemiol; 2016 Apr; 41():132-8. PubMed ID: 26953842
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of cancer survival across South-Western Victoria in Australia.
Wong SF; Matheson L; Morrissy K; Pitson G; Ashley DM; Khasraw M; Lorgelly PK; Henry MJ
Aust J Rural Health; 2016 Apr; 24(2):79-84. PubMed ID: 26122852
[TBL] [Abstract][Full Text] [Related]
6. Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: is the age-related gap narrowing?
Pinkerton R; Wills RA; Coory MD; Fraser CJ
Med J Aust; 2010 Aug; 193(4):217-21. PubMed ID: 20712542
[TBL] [Abstract][Full Text] [Related]
7. The incidence of and mortality from leukaemias in the UK: a general population-based study.
Bhayat F; Das-Gupta E; Smith C; McKeever T; Hubbard R
BMC Cancer; 2009 Jul; 9():252. PubMed ID: 19630999
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
[TBL] [Abstract][Full Text] [Related]
9. Socio-demographic disadvantage and distant summary stage of cancer at diagnosis--A population-based study in New South Wales.
Tervonen HE; Walton R; Roder D; You H; Morrell S; Baker D; Aranda S
Cancer Epidemiol; 2016 Feb; 40():87-94. PubMed ID: 26703888
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review.
Yeoh DK; Moore AS; Kotecha RS; Bartlett AW; Ryan AL; Cann MP; McMullan BJ; Thursky K; Slavin M; Blyth CC; Haeusler GM; Clark JE
Pediatr Blood Cancer; 2021 Nov; 68(11):e29275. PubMed ID: 34357688
[TBL] [Abstract][Full Text] [Related]
11. Aboriginal premature mortality within South Australia 1999-2006: a cross-sectional analysis of small area results.
Banham D; Jury H; Woollacott T; McDermott R; Baum F
BMC Public Health; 2011 May; 11():286. PubMed ID: 21554738
[TBL] [Abstract][Full Text] [Related]
12. Effect of socio-economic status & proximity of patient residence to hospital on survival in childhood acute lymphoblastic leukaemia.
Totadri S; Trehan A; Kaur A; Bansal D
Indian J Med Res; 2019 Jan; 149(1):26-33. PubMed ID: 31115371
[TBL] [Abstract][Full Text] [Related]
13. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
14. Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Stubbins RJ; Stamenkovic M; Roy C; Rodrigo J; Chung S; Kuchenbauer FC; Hay KA; White J; Abou Mourad Y; Power MM; Narayanan S; Forrest DL; Toze CL; Sutherland HJ; Nantel SH; Nevill TJ; Karsan A; Song KW; Sanford DS
Eur J Haematol; 2022 May; 108(5):437-445. PubMed ID: 35122325
[TBL] [Abstract][Full Text] [Related]
15. Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL)).
Küley-Bagheri Y; Kreuzer KA; Monsef I; Lübbert M; Skoetz N
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011960. PubMed ID: 30080246
[TBL] [Abstract][Full Text] [Related]
16. Developing a comorbidity index for comparing cancer outcomes in Aboriginal and non-Aboriginal Australians.
Pule L; Buckley E; Niyonsenga T; Banham D; Roder D
BMC Health Serv Res; 2018 Oct; 18(1):776. PubMed ID: 30326898
[TBL] [Abstract][Full Text] [Related]
17. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales.
Tervonen HE; Walton R; You H; Baker D; Roder D; Currow D; Aranda S
BMC Cancer; 2017 Jun; 17(1):398. PubMed ID: 28577351
[TBL] [Abstract][Full Text] [Related]
18. The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.
Foresto SA; Youlden DR; Baade PD; Hallahan AR; Aitken JF; Moore AS
Pediatr Blood Cancer; 2015 Sep; 62(9):1664-6. PubMed ID: 25855531
[TBL] [Abstract][Full Text] [Related]
19. Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis.
Canaani J; Beohou E; Labopin M; Ghavamzadeh A; Beelen D; Hamladji RM; Niederwieser D; Volin L; Markiewicz M; Arnold R; Mufti G; Ehninger G; Socié G; Kröger N; Mohty M; Nagler A
J Intern Med; 2019 Apr; 285(4):407-418. PubMed ID: 30372796
[TBL] [Abstract][Full Text] [Related]
20. Acute myelogenous leukaemia in children under 2 years--experiences of the West German AML studies BFM-78, -83 and -87. AML-BFM Study Group.
Vormoor J; Ritter J; Creutzig U; Boos J; Heyen P; Ludwig WD; Harbott J; Löffler H; Schellong G
Br J Cancer Suppl; 1992 Aug; 18():S63-7. PubMed ID: 1503929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
